Krzysztof Szafrański

Author

Gdańsk Medical University ORCID

Also Known As

Krzysztof Szafrański, Szafrański, Krzysztof

Publications

346

Citations

H-Index

Concepts

All Affiliations

Gdańsk Medical University University of Florence Gdańsk University of Technology

About

Krzysztof Szafrański is an author at Gdańsk Medical University specializing in drug discovery, medicinal chemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	206
2	Natural Sciences	6	6	206
3	Pharmacology	6	6	206
4	Biochemistry	5	5	148
5	Chemistry	1	1	58

Krzysztof Szafrański

Publications

321

Citations

H-Index

Page 1

	Year	Citations
Novel 2-benzylthio-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides with anticancer activity: Synthesis, QSAR study, and metabolic stability Jarosław Sławiński, Krzysztof Szafrański, Aneta Pogorzelska, European Journal of Medicinal Chemistry Medicinal ChemistryMetabolic StabilityHeterocyclicNatural SciencesMedicine	2017	58
Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII Jarosław Sławiński, Krzysztof Szafrański, Daniela Vullo, European Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryMedicineTumor-associated Isozymes IxNatural Sciences	2013	52
Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies Beata Żołnowska, Jarosław Sławiński, Krzysztof Szafrański, European Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryMedicineNatural SciencesGuanidine Derivatives	2017	33
Synthesis of a new series of N4-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII Jarosław Sławiński, Zdzisław Brzozowski, Beata Żołnowska, European Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryNatural SciencesTumor-associated Isozymes IxMedicine	2014	23
Novel 5-Substituted 2-(Aylmethylthio)-4-chloro-N-(5-aryl-1,2,4-triazin-3-yl)benzenesulfonamides: Synthesis, Molecular Structure, Anticancer Activity, Apoptosis-Inducing Activity and Metabolic Stability Beata Żołnowska, Jarosław Sławiński, Aneta Pogorzelska, Molecules Benzenesulfonamide Derivatives 27-60Chemoprevention StrategyMcf-7 Cell LinesCellular PharmacologyOrganic Chemistry	2016	20
Novel 2-(2-alkylthiobenzenesulfonyl)-3-(phenylprop-2-ynylideneamino)guanidine derivatives as potent anticancer agents – Synthesis, molecular structure, QSAR studies and metabolic stability Aneta Pogorzelska, Jarosław Sławiński, Beata Żołnowska, European Journal of Medicinal Chemistry Qsar StudiesMedicinal ChemistryDiversity Oriented SynthesisDerivativesMetabolic Stability	2017	20
Syntheses of Novel 4-Substituted N-(5-amino-1H-1,2,4-triazol-3-yl)pyridine-3-sulfonamide Derivatives with Potential Antifungal Activity Krzysztof Szafrański, Jarosław Sławiński, Anna Kędzia, Molecules	2017	19
Synthesis of Novel 1-(4-Substituted pyridine-3-sulfonyl)-3-phenylureas with Potential Anticancer Activity Krzysztof Szafrański, Jarosław Sławiński Molecules	2015	16
Synthesis, Molecular Structure, Metabolic Stability and QSAR Studies of a Novel Series of Anticancer N-Acylbenzenesulfonamides Beata Żołnowska, Jarosław Sławiński, Mariusz Belka, Molecules	2015	16
Target-based drug discovery through inversion of quantitative structure-drug-property relationships and molecular simulation: CA IX-sulphonamide complexes Petar Žuvela, Jay Liu, Myunggi Yi, Journal of Enzyme Inhibition and Medicinal Chemistry	2018	16

Page 1